Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Cyclin-Dependent Kinase Inhibitor p19 MeSH Descriptor Data 2025


MeSH Heading
Cyclin-Dependent Kinase Inhibitor p19
Tree Number(s)
D12.644.360.225.400
D12.776.167.187.400
D12.776.476.225.400
D12.776.624.776.355.400
Unique ID
D050764
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D050764
Scope Note
An INK4 cyclin-dependent kinase inhibitor containing five ANKYRIN REPEATS. Aberrant expression of this protein has been associated with TESTICULAR CANCER.
Entry Term(s)
CDKN2D Protein
Cyclin-Dependent Kinase Inhibitor 2D
INK4D Protein
p19INK4D Protein
Pharm Action
Protein Kinase Inhibitors
Registry Numbers
0
Public MeSH Note
2006; CYCLIN-DEPENDENT KINASE INHIBITOR P19 was indexed under CARRIER PROTEINS 1995-2001, under PROTEIN P16 2002-2004, & under CELL CYCLE PROTEINS 2005
History Note
2006(1995)
Date Established
2006/01/01
Date of Entry
2005/06/30
Revision Date
2015/11/23
Cyclin-Dependent Kinase Inhibitor p19 Preferred
page delivered in 0.137s